Article info
Hepatology
Original research
TGF-β2 silencing to target biliary-derived liver diseases
- Correspondence to Steven Dooley, Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, University of Heidelberg, Mannheim 68167, Germany; steven.dooley{at}medma.uni-heidelberg.de; Nadja M Meindl-Beinker; Nadja.Meindl-Beinker{at}medma.uni-heidelberg.de
Citation
TGF-β2 silencing to target biliary-derived liver diseases
Publication history
- Received May 15, 2019
- Revised December 16, 2019
- Accepted December 17, 2019
- First published January 28, 2020.
Online issue publication
February 12, 2021
Article Versions
- Previous version (12 February 2021).
- Previous version (12 February 2021).
- Previous version (12 February 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.